Physician profile
Om P Singh
NPI 1023115193
$693.98
in general payments reported to CMS, 2019-2025
11 companies · $65.59 in 2025
The $65.59 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $243 · 2021: $172 · 2022: $53.02 · 2023: $78.13 · 2024: $81.87 · 2025: $65.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $225.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $134.89 | 2020-2024 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $92.95 | 2021-2024 | Airsupra, Farxiga |
| Lilly USA, LLC | $92.04 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $72.26 | 2020-2021 | |
| Biocomposites INC | $65.59 | 2025 | Stimulan |
| Janssen Pharmaceuticals, INC | $56.56 | 2020-2021 | |
| Glaxosmithkline, LLC. | $48.82 | 2023-2024 | Trelegy Ellipta, Arexvy |
| Exact Sciences Corporation | $42.87 | 2023-2024 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.86 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.23 | 2020-2021 | |
| Lucid Diagnostics INC. | $12.91 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Om Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.